Navana Pharmaceuticals Balance Sheet

Financials in millions BDT. Fiscal year is July - June.

Millions BDT. Fiscal year is Jul - Jun.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep '24 Sep 30, 2024	Jun '24 Jun 30, 2024	Jun '23 Jun 30, 2023	Jun '22 Jun 30, 2022	Jun '21 Jun 30, 2021	Jun '20 Jun 30, 2020
Cash & Equivalents	270.83	267.77	440.93	66.43	25.78	54.72
Cash & Short-Term Investments	270.83	267.77	440.93	66.43	25.78	54.72
Cash Growth	-24.31%	-39.27%	563.78%	157.71%	-52.89%	-
Accounts Receivable	1,085	996.56	788.15	519.97	434.81	360.4
Other Receivables	30.09	23.57	13.09	27.85	28.08	75.42
Receivables	1,115	1,020	801.24	547.82	462.89	435.82
Inventory	2,445	2,303	1,554	1,170	931.44	826.17
Prepaid Expenses	-	-	0.95	2.59	1.98	1.86
Other Current Assets	1,850	1,890	1,993	1,109	387.04	309.93
Total Current Assets	5,681	5,480	4,789	2,895	1,809	1,628
Property, Plant & Equipment	5,741	5,746	4,632	4,029	3,389	2,799
Long-Term Investments	50.18	76.92	167.62	159.03	-	-
Other Intangible Assets	0.28	0.33	0.55	0.77	0.99	-
Long-Term Deferred Tax Assets	-	-	-	-	-	23.76
Other Long-Term Assets	-	-	-	-	0	-
Total Assets	11,472	11,304	9,590	7,084	5,199	4,451
Accounts Payable	8.71	23.79	44.46	42.65	20.43	34.19
Accrued Expenses	448.76	444.32	298.32	245.36	185.09	161.28
Short-Term Debt	5,162	5,008	4,066	2,682	1,143	782.7
Current Portion of Long-Term Debt	40.66	35.37	18.09	28.13	18.8	71.31
Current Portion of Leases	40.86	43.55	34.72	29.25	34.62	24.13
Current Income Taxes Payable	288.57	451.2	345.48	245.11	141.44	161.28
Other Current Liabilities	279.47	288.36	47.84	14.02	28.31	8.23
Total Current Liabilities	6,269	6,295	4,855	3,287	1,572	1,243
Long-Term Debt	259.66	225.32	120.63	171.39	162.98	60.9
Long-Term Leases	65.83	64.5	89.6	100.72	131.53	27.58
Long-Term Deferred Tax Liabilities	203.33	158.01	152.11	42.36	28.25	17.3
Other Long-Term Liabilities	-0	-	0	-	-0	-
Total Liabilities	6,798	6,743	5,217	3,601	1,895	1,349
Common Stock	1,074	1,074	1,074	802.3	802.3	0.8
Additional Paid-In Capital	448.17	448.17	448.17	-	-	-
Retained Earnings	841.77	708.02	443.03	204.24	535.83	1,135
Comprehensive Income & Other	2,310	2,331	2,407	2,477	1,966	1,966
Shareholders' Equity	4,674	4,561	4,372	3,483	3,304	3,102
Total Liabilities & Equity	11,472	11,304	9,590	7,084	5,199	4,451
Total Debt	5,569	5,377	4,329	3,012	1,491	966.62
Net Cash (Debt)	-5,248	-5,032	-3,721	-2,786	-1,466	-911.9
Net Cash Per Share	-48.72	-46.85	-37.42	-34.73	-18.27	-11.37
Filing Date Shares Outstanding	107.42	107.42	107.42	80.23	80.23	80.23
Total Common Shares Outstanding	107.42	107.42	107.42	80.23	80.23	80.23
Working Capital	-588.36	-814.39	-65.55	-391.14	237.08	385.38
Book Value Per Share	43.51	42.46	40.71	43.41	41.19	38.67
Tangible Book Value	4,674	4,561	4,372	3,482	3,303	3,102
Tangible Book Value Per Share	43.51	42.46	40.70	43.40	41.17	38.67
Land	-	2,483	2,483	2,483	2,483	2,474
Buildings	-	1,415	1,142	745.82	231.9	185.08
Machinery	-	1,708	985.02	831.81	789.03	539.94
Construction In Progress	730.92	931.72	614.67	403.01	159.04	-

Source: S&P Capital IQ. Standard template. Financial Sources.